Authors: MACKE HR BEHE M FROIDEVAUX S HEPPELER A JERMANN E

Citation: Hr. Macke et al., DOTA-D-PHE(1)-TYR(3)-OCTREOTIDE (DOTATOC) A UNIQUE SOMATOSTATIN RECEPTOR-LIGAND FOR LABELING WITH A VARIETY OF METALLIC RADIONUKLIDES, The Journal of nuclear medicine, 38(5), 1997, pp. 57-57

Authors: POURTIERMANZANEDO A DIDIER A FROIDEVAUX S LOOR F

Citation: A. Pourtiermanzanedo et al., LYMPHOTOXICITY AND MYELOTOXICITY OF DOXORUBICIN AND SDZ PSC-833 COMBINED CHEMOTHERAPIES FOR NORMAL MICE, Toxicology, 99(3), 1995, pp. 207-217

Authors: FROIDEVAUX S LOOR F

Citation: S. Froidevaux et F. Loor, MYELOID AND LYMPHOID-CELL ALTERATIONS IN NORMAL MICE EXPOSED TO CHEMOTHERAPY WITH DOXORUBICIN AND OR THE MULTIDRUG-RESISTANCE REVERSING AGENT SDZ-PSC-833/, International journal of cancer, 59(1), 1994, pp. 133-140

Authors: VELIN D GOETTELFINGER P FROIDEVAUX S LOOR F

Citation: D. Velin et al., GLD AND LPR HEMATOPOIETIC-CELL TRANSFERS - COMMON AND DIFFERENT SEROLOGICAL FEATURES OF THE C57BL 6 CHIMERAS/, Cellular immunology, 148(2), 1993, pp. 331-345